TYPE SIZE:
I am/I care for a patient with cancer

Bookmark and Share

Cancer Clinical Trial Resources

Cancer Survivor Survey Results

A survey entitled “CANCER CLINICAL TRIALS AWARENESS AND ATTITUDES IN CANCER SURVIVORS,” was conducted by the Coalition of Cancer Cooperative Groups and Northwestern University in 2005. Robert L. Comis, MD, president and chairman of the Coalition of Cancer Cooperative Groups and Jon D. Miller, PhD, professor and director of the Center for Biomedical Communications at the Feinberg School of Medicine, Northwestern University, developed the survey and analyzed its data. The following information captures the results from nearly 2000 US cancer survivors polled.

How many newly diagnosed cancer patients report that they were aware of the possibility of participating in a cancer clinical trial at time of diagnosis?

Are there disparities in awareness among cancer patients with different tumor types?

Are there disparities in awareness among cancer patients with different types of treatment?

What percentage of cancer survivors participate in cancer clinical trials in the United States?

What were the perceptions of advantages to enrollment in a Cancer Clinical Trial among survivors who were aware of the possibility of a trial at the time of diagnosis, and enrolled?

What were the sources of awareness of cancer clinical trials?

How many cancer patients are needed to complete all of the cancer clinical trials currently underway in the United States? What are the consequences of a shortfall in patient enrollment?

Are cancer survivors satisfied with their cancer clinical trial experience?